(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded ...

Patients report that GLP-1 drugs like Ozempic and Mounjaro reduce “food noise,” the constant mental chatter about eating.

Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at ...

Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's ...

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

Despite carbohydrates being an essential macronutrient, when it comes to weight loss, carbs like pasta, rice, corn, bread and ...

Food nutrition company Glanbia Plc is exiting SlimFast, the meal replacement brand that has struggled in recent years as ...

If you're struggling to lose weight, try avoiding breakfast mistakes that can derail your goals, like poor meal timing and ...

Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.